Contact Us
Drug Search Results
More Filters [+]

Valomaciclovir

Alternative Names: valomaciclovir, epb-348, epb348, epb 348
Latest Update: 2024-06-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DNA Polymerase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Epiphany Biosciences
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Valomaciclovir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Herpes Zoster|Infectious Mononucleosis|Communicable Diseases|Epstein-Barr Virus Infections

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Mono6

P2

Completed

Communicable Diseases|Epstein-Barr Virus Infections|Infectious Mononucleosis

2009-07-01

EPB348-0201

P2

Completed

Herpes Zoster

2009-06-01

Recent News Events

Date

Type

Title

06/01/2024

PubMed

 Computational analysis of antiviral drugs using topological descriptors.

05/09/2024

PubMed

 Characteristics of Prescreened Patients Who Did Not Participate in the Zoster Eye Disease Study.

05/06/2024

PubMed

 Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions